Levels of protective antibodies against omicron are “transient” after the second and third doses of Pfizer’s Covid-19 vaccine, researchers found.
Levels of protective antibodies against omicron are “transient” after the second and third doses of Pfizer’s Covid-19 vaccine, researchers found.